These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19661437)

  • 1. Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.
    Li X; Gonzalez ME; Toy K; Filzen T; Merajver SD; Kleer CG
    Am J Pathol; 2009 Sep; 175(3):1246-54. PubMed ID: 19661437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.
    Michalak EM; Nacerddine K; Pietersen A; Beuger V; Pawlitzky I; Cornelissen-Steijger P; Wientjens E; Tanger E; Seibler J; van Lohuizen M; Jonkers J
    Stem Cells; 2013 Sep; 31(9):1910-20. PubMed ID: 23712803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer.
    Wu J; Crowe DL
    Oncol Rep; 2015 Jul; 34(1):455-60. PubMed ID: 25998860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
    Zhang J; Li Y; Liu Q; Lu W; Bu G
    Oncogene; 2010 Jan; 29(4):539-49. PubMed ID: 19881541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast.
    Ding L; Kleer CG
    Cancer Res; 2006 Oct; 66(19):9352-5. PubMed ID: 17018586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer.
    Doherty LF; Bromer JG; Zhou Y; Aldad TS; Taylor HS
    Horm Cancer; 2010 Jun; 1(3):146-55. PubMed ID: 21761357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
    Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
    Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.
    Teulière J; Faraldo MM; Deugnier MA; Shtutman M; Ben-Ze'ev A; Thiery JP; Glukhova MA
    Development; 2005 Jan; 132(2):267-77. PubMed ID: 15590737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.
    Puppe J; Drost R; Liu X; Joosse SA; Evers B; Cornelissen-Steijger P; Nederlof P; Yu Q; Jonkers J; van Lohuizen M; Pietersen AM
    Breast Cancer Res; 2009; 11(4):R63. PubMed ID: 19709408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration.
    Bray K; Gillette M; Young J; Loughran E; Hwang M; Sears JC; Vargo-Gogola T
    Breast Cancer Res; 2013; 15(5):R91. PubMed ID: 24074261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone methyltransferase EZH2 is required for normal uterine development and function in mice†.
    Nanjappa MK; Mesa AM; Medrano TI; Jefferson WN; DeMayo FJ; Williams CJ; Lydon JP; Levin ER; Cooke PS
    Biol Reprod; 2019 Aug; 101(2):306-317. PubMed ID: 31201420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor drives hepatocellular carcinogenesis by activating enhancer of zeste homolog 2-mediated Wnt/β-catenin signaling.
    Song H; Yu Z; Sun X; Feng J; Yu Q; Khan H; Zhu X; Huang L; Li M; Mok MTS; Cheng ASL; Gao Y; Feng H
    EBioMedicine; 2018 Sep; 35():155-166. PubMed ID: 30150059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of estrogen and Wnt signaling circuits by the polycomb group protein EZH2 in breast cancer cells.
    Shi B; Liang J; Yang X; Wang Y; Zhao Y; Wu H; Sun L; Zhang Y; Chen Y; Li R; Zhang Y; Hong M; Shang Y
    Mol Cell Biol; 2007 Jul; 27(14):5105-19. PubMed ID: 17502350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
    Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
    Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.
    Roy BC; Subramaniam D; Ahmed I; Jala VR; Hester CM; Greiner KA; Haribabu B; Anant S; Umar S
    Oncogene; 2015 Aug; 34(34):4519-30. PubMed ID: 25486432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.
    Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L
    Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase CK2 in mammary gland tumorigenesis.
    Landesman-Bollag E; Romieu-Mourez R; Song DH; Sonenshein GE; Cardiff RD; Seldin DC
    Oncogene; 2001 May; 20(25):3247-57. PubMed ID: 11423974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
    Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
    Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.